Literature DB >> 16861001

High-level expression of nonglycosylated human pancreatic lipase-related protein 2 in Pichia pastoris.

Corinne Sebban-Kreuzer1, Paule Deprez-Beauclair, Amelie Berton, Isabelle Crenon.   

Abstract

The human pancreatic lipase-related protein 2 (HPLRP2) was produced in the methylotrophic yeast Pichia pastoris. The HPLRP2 cDNA corresponding to the protein coding sequence including the native signal sequence, was cloned into the pPIC9K vector and integrated into the genome of P. pastoris. P. pastoris transformants secreting high-level rHPLRP2 were obtained and the expression level into the liquid culture medium reached about 40mg/L after 4 days of culture. rHPLRP2 was purified by a single anion-exchange step after an overnight dialysis. N-terminal sequence analysis showed that the purified rHPLRP2 mature protein possessed a correct N-terminal amino acid sequence indicating that its signal peptide was properly processed. Mass spectrometry analysis showed that the recombinant HPLRP2 molecular weight was 52,532Da which was 2451Da greater than the mass calculated from the sequence of the protein (50,081Da) and 1536Da greater than the mass of the native human protein (50,996Da). In vitro deglycosylation experiments by peptide:N-glycosidase F (PNGase F) indicated that rHPLRP2 secreted from P. pastoris was N-glycosylated. Specific conditions were setup in order to obtain a recombinant protein free of glycan chain. We observed that blocking glycosylation in vivo by addition of tunicamycin in the culture medium during the production resulted in a correct processing of the rHPLRP2 mature protein. The lipase activity of glycosylated or nonglycosylated rHPLRP2, which was about 800U/mg on tributyrin, was inhibited by the presence of bile salts and not restored by adding colipase. In conclusion, the experimental procedure which we have developed will allow us to get a high-level production in P. pastoris of glycosylated and nonglycosylated rHPLRP2, suitable for subsequent biophysical and structural studies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16861001     DOI: 10.1016/j.pep.2006.06.001

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  5 in total

1.  Strains and Molecular Tools for Recombinant Protein Production in Pichia pastoris.

Authors:  Claudia Rinnofner; Michael Felber; Harald Pichler
Journal:  Methods Mol Biol       Date:  2022

2.  Quinovosamycins: new tunicamycin-type antibiotics in which the α, β-1″,11'-linked N-acetylglucosamine residue is replaced by N-acetylquinovosamine.

Authors:  Neil Pj Price; David P Labeda; Todd A Naumann; Karl E Vermillion; Michael J Bowman; Mark A Berhow; William W Metcalf; Kenneth M Bischoff
Journal:  J Antibiot (Tokyo)       Date:  2016-05-18       Impact factor: 2.649

3.  Engineering a leucine zipper-TRAIL homotrimer with improved cytotoxicity in tumor cells.

Authors:  Dmitri V Rozanov; Alexei Y Savinov; Vladislav S Golubkov; Olga L Rozanova; Tatiana I Postnova; Eduard A Sergienko; Stefan Vasile; Alexander E Aleshin; Michele F Rega; Maurizio Pellecchia; Alex Y Strongin
Journal:  Mol Cancer Ther       Date:  2009-06-09       Impact factor: 6.261

4.  Purification and characterization of the first recombinant bird pancreatic lipase expressed in Pichia pastoris: the turkey.

Authors:  Madiha Bou Ali; Yassine Ben Ali; Aida Karray; Ahmed Fendri; Youssef Gargouri
Journal:  Lipids Health Dis       Date:  2011-01-27       Impact factor: 3.876

5.  Partial optimization of the 5-terminal codon increased a recombination porcine pancreatic lipase (opPPL) expression in Pichia pastoris.

Authors:  Hua Zhao; Dan Chen; Jiayong Tang; Gang Jia; Dingbiao Long; Guangmang Liu; Xiaoling Chen; Haiying Shang
Journal:  PLoS One       Date:  2014-12-29       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.